Skip to main content
. 2013 Feb 6;6:10. doi: 10.1186/1757-2215-6-10

Table 4.

Toxicity in subsequent lines of treatment (Grade ≥ 2)

  PLD arm Other treatment
Neutropenia
 14%
  20%
Thrombocytopenia
 7%
  12%
Anemia
 1%
  3%
Hand–foot syndrome
 5%
  0%
Oral toxicity
 5%
  3%
Neurological toxicity  1%   7%